Literature DB >> 18089500

Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.

Ken H Young1, Qingmei Xie, Guimei Zhou, Jens C Eickhoff, Warren G Sanger, Patricia Aoun, Wing C Chan.   

Abstract

Progression of follicular lymphoma (FL) to a higher-grade lymphoma occurs in 25% to 60% of cases and frequently indicates a poor prognosis. The transformation is accompanied by alteration in morphologic features and clinical behaviors. Herein, we report a case of FL occurring in a 59-year-old woman with the development of a precursor B-cell lymphoblastic lymphoma (PBC-LBL) during a 6-month period. Both lymphomas had identical bcl-2 and immunoglobulin heavy-chain gene breakpoints as assessed by polymerase chain reaction amplification and direct sequencing, indicating that the 2 tumors originated from a common precursor B-cell clone or the PBC-LBL arose from clonal evolution of its preceding FL and "dedifferentiated" into a lymphoblastic stage. Immunohistochemical studies revealed that both lymphomas displayed typical phenotypic characteristics. A c-myc gene translocation was observed in the PBC-LBL but not the FL by fluorescence in situ hybridization. The c-myc translocation is also reported in similar cases in the literature and likely is crucial in the pathogenesis of the PBC-LBL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18089500     DOI: 10.1309/NKK3FEX2BE5L7EKB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 2.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

3.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Authors:  Laura Moench; Zohar Sachs; Garth Aasen; Michelle Dolan; Vanessa Dayton; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2016-02-18

Review 4.  Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Authors:  Xiaoxiao Xu; Le Zhang; Yafei Wang; Qing Zhang; Lianyu Zhang; Baocun Sun; Yizhuo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

5.  Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Andrew L Feldman; Rhett P Ketterling; Ryan Knudson; Jaime Rodriguez-Canales; Jeffrey Hanson; Stefania Pittaluga; Elaine S Jaffe
Journal:  Mod Pathol       Date:  2011-06-10       Impact factor: 7.842

Review 6.  Atypical Burkitt's lymphoma transforming from follicular lymphoma.

Authors:  Yu Y Hwang; Florence Loong; Lap P Chung; Chor S Chim
Journal:  Diagn Pathol       Date:  2011-07-08       Impact factor: 2.644

7.  MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.

Authors:  Ja-Young Seo; Soo Hyun Lee; Hee-Jin Kim; Keon Hee Yoo; Hong Hoe Koo; Yong Gon Cho; Sam Im Choi; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

Review 8.  MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management.

Authors:  Qingqing Cai; L Jeffrey Medeiros; Xiaolu Xu; Ken H Young
Journal:  Oncotarget       Date:  2015-11-17

9.  Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.

Authors:  T K Moyo; C S Wilson; D J Moore; C M Eischen
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

10.  High-Grade B-Cell Neoplasm with Surface Light Chain Restriction and Tdt Coexpression Evolved in a MYC-Rearranged Diffuse Large B-Cell Lymphoma: A Dilemma in Classification.

Authors:  Dina Sameh Soliman; Ahmad Al-Sabbagh; Feryal Ibrahim; Ruba Y Taha; Zafar Nawaz; Sarah Elkourashy; Abdulrazzaq Haider; Susanna Akiki; Mohamed Yassin
Journal:  Case Rep Hematol       Date:  2017-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.